MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Umoja Biopharma
Organization & Developments: Umoja Biopharma
Parents
Umoja Biopharma
Children
Umoja Biopharma is pioneering the use of immunotherapy for solid tumors by reprogramming T cells in vivo, rather than ex vivo, using CAR-T cell therapy
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer
Jumps
Finance & Acquisitions: Umoja Biopharma
Key People: Umoja Biopharma